Cite
HARVARD Citation
Vogel, A. et al. (n.d.). 2358 Efficacy and safety of nab-Paclitaxel (nab-P) plus gemcitabine (Gem) vs gem alone in patients (Pts) with metastatic pancreatic cancer (MPC) treated to progressive disease (PD) in the phase III MPACT trial. European journal of cancer. pp. S455-. [Online].